2024 annual financial data
CG Oncology 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -6,910.71%.
Operating income was -114,666,000 USD and net income was -88,039,000 USD.
Operating cash flow was -78,713,000 USD.
Get free CG Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,139,000 USD
- Operating income
- -114,666,000 USD
- Net income
- -88,039,000 USD
- Operating cash flow
- -78,713,000 USD